Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Germinoma Mimicking Brain Inflammation: A Case Report.

Pierzchlewicz K, Bilska M, Jurkiewicz E, Chmielewski D, Moszczyńska E, Daszkiewicz P, Ciołkowski M, Grajkowska W, Kotulska K.

Child Neurol Open. 2019 May 20;6:2329048X19848181. doi: 10.1177/2329048X19848181. eCollection 2019.

2.

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.

Okła K, Czerwonka A, Wawruszak A, Bobiński M, Bilska M, Tarkowski R, Bednarek W, Wertel I, Kotarski J.

Front Immunol. 2019 Apr 3;10:691. doi: 10.3389/fimmu.2019.00691. eCollection 2019.

3.

Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review.

Bilski M, Surdyka D, Paśnik I, Bilska M, Cisek P, Korona P, Szumiło J, Grzybowska-Szatkowska L.

Case Rep Oncol Med. 2018 Feb 11;2018:8672407. doi: 10.1155/2018/8672407. eCollection 2018.

4.

Novel patterns of left ventricular mechanical activity during experimental cardiac arrest in pigs.

Skulec R, Astapenko D, Cerna Parizkova R, Furst B, Bilska M, Parizek T, Hovanec T, Pinterova N, Knor J, Dudakova J, Truhlar A, Radochova V, Zadak Z, Cerny V.

Physiol Res. 2018 Jul 17;67(3):391-399. Epub 2018 Mar 12.

5.

[Why ovarian cancer cells escape from immune surveillance?]

Wertel I, Okła K, Surówka J, Bilska M, Polak G, Bednarek W, Kotarski J.

Wiad Lek. 2017;70(1):74-80. Review. Polish.

PMID:
28343198
6.

Spinal cord lesions in children and adolescents with multiple sclerosis - Magnetic resonance imaging.

Dębska J, Kotulska-Józwiak K, Pawliszak P, Bilska M, Chmielewski D, Puzio I, Jurkiewicz E.

Neurol Neurochir Pol. 2017 Jan - Feb;51(1):77-81. doi: 10.1016/j.pjnns.2016.11.008. Epub 2016 Dec 14.

PMID:
28038775
7.

Short Communication: Potential Risk of Replication-Competent Virus in HIV-1 Env-Pseudotyped Virus Preparations.

Bilska M, Tang H, Montefiori DC.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):368-372. doi: 10.1089/AID.2016.0142. Epub 2016 Nov 1.

8.

[Assessment of regulatory T cells, cytotoxic lymphocytes and dendritic cells in ovarian cancer patients before and after menopause].

Surówka JA, Wertel I, Polak G, Okła K, Bilska M, Kotarski J.

Ginekol Pol. 2016;87(1):11-8. doi: 10.17772/gp/60976. English, Polish. No abstract available.

9.

Targeting bacterial biofilms via surface engineering of gold nanoparticles.

Giri K, Yepes LR, Duncan B, Parameswaran PK, Yan B, Jiang Y, Bilska M, Moyano DF, Thompson M, Rotello VM, Prakash YS.

RSC Adv. 2015;5(128):105551-105559. Epub 2015 Dec 1.

10.

Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries.

Jurkiewicz E, Kotulska K, Nowak K, Malczyk K, Borkowska J, Bilska M.

Childs Nerv Syst. 2015 Sep;31(9):1601-6. doi: 10.1007/s00381-015-2731-5. Epub 2015 May 13.

11.

[The prognostic value of selected immunological factors in ovarian cancer patients].

Bilska M, Wertel I, Surówka J, Okła K, Bilski M, Tarkowski R, Kotarski J.

Wiad Lek. 2015;68(4 Pt 2):690-4. Review. Polish.

PMID:
27162313
12.

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.

Kotulska K, Borkowska J, Mandera M, Roszkowski M, Jurkiewicz E, Grajkowska W, Bilska M, Jóźwiak S.

Childs Nerv Syst. 2014 Dec;30(12):2037-42. doi: 10.1007/s00381-014-2555-8. Epub 2014 Sep 17.

13.

Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.

Sarzotti-Kelsoe M, Daniell X, Todd CA, Bilska M, Martelli A, LaBranche C, Perez LG, Ochsenbauer C, Kappes JC, Rountree W, Denny TN, Montefiori DC.

J Immunol Methods. 2014 Jul;409:147-60. doi: 10.1016/j.jim.2014.02.013. Epub 2014 Mar 6.

14.

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.

Sholukh AM, Byrareddy SN, Shanmuganathan V, Hemashettar G, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Thorat S, Brandstoetter T, Mukhtar MM, Yoon JK, Novembre FJ, Villinger F, Landucci G, Forthal DN, Ratcliffe S, Tuero I, Robert-Guroff M, Polonis VR, Bilska M, Montefiori DC, Johnson WE, Ertl HC, Ruprecht RM.

Retrovirology. 2014 Jan 20;11:8. doi: 10.1186/1742-4690-11-8.

15.

MR venography in children and adolescents with multiple sclerosis does not show increased prevalence of extracranial veins anomalies.

Jurkiewicz E, Kotulska K, Nowak K, Chełstowska S, Armata M, Chmielewski D, Bilska M.

Eur J Paediatr Neurol. 2014 Mar;18(2):218-22. doi: 10.1016/j.ejpn.2013.11.013. Epub 2013 Dec 25.

PMID:
24411179
16.

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

Sarzotti-Kelsoe M, Bailer RT, Turk E, Lin CL, Bilska M, Greene KM, Gao H, Todd CA, Ozaki DA, Seaman MS, Mascola JR, Montefiori DC.

J Immunol Methods. 2014 Jul;409:131-46. doi: 10.1016/j.jim.2013.11.022. Epub 2013 Dec 1.

17.

Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells.

Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK.

J Virol. 2013 Nov;87(21):11924-9. doi: 10.1128/JVI.02128-13. Epub 2013 Aug 21.

18.

Adsorption of Remazol Red 198 onto magnetic N-lauryl chitosan particles: equilibrium, kinetics, reuse and factorial design.

Debrassi A, Baccarin T, Demarchi CA, Nedelko N, Ślawska-Waniewska A, Dłużewski P, Bilska M, Rodrigues CA.

Environ Sci Pollut Res Int. 2012 Jun;19(5):1594-604. doi: 10.1007/s11356-011-0662-6. Epub 2011 Dec 2.

PMID:
22134860
19.

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.

Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, Chen B, Parks R, Foulger A, Jaeger F, Donathan M, Bilska M, Gray ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody MA, Liao HX, Haynes BF.

PLoS One. 2011;6(9):e23532. doi: 10.1371/journal.pone.0023532. Epub 2011 Sep 30.

20.

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.

Geonnotti AR, Bilska M, Yuan X, Ochsenbauer C, Edmonds TG, Kappes JC, Liao HX, Haynes BF, Montefiori DC.

AIDS Res Hum Retroviruses. 2010 Mar;26(3):279-91. doi: 10.1089/aid.2009.0186.

21.

Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.

Platt EJ, Bilska M, Kozak SL, Kabat D, Montefiori DC.

J Virol. 2009 Aug;83(16):8289-92. doi: 10.1128/JVI.00709-09. Epub 2009 May 27.

22.

Synthesis and immunosuppressive activity of new cyclolinopeptide A analogs modified with beta-prolines.

Katarzyńska J, Mazur A, Bilska M, Adamek E, Zimecki M, Jankowski S, Zabrocki J.

J Pept Sci. 2008 Dec;14(12):1283-94. doi: 10.1002/psc.1069.

PMID:
18821729
23.

[Juvenile form of Alexander's disease - a case confirmed by detection of mutation in GFAP gene].

Kmieć T, Bilska M, Mierzewska H, Jurkiewicz E, Jóźwiak S.

Neurol Neurochir Pol. 2007 May-Jun;41(3):267-71. Polish.

PMID:
17629821
24.

Role of gap junctions in regulation of progesterone secretion by ovine luteal cells in vitro.

Borowczyk E, Johnson ML, Bilski JJ, Bilska MA, Redmer DA, Reynolds LP, Grazul-Bilska AT.

Reproduction. 2007 Mar;133(3):641-51.

PMID:
17379658
25.

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.

Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC.

J Virol. 2006 Dec;80(23):11776-90. Epub 2006 Sep 13.

26.

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC.

J Virol. 2005 Aug;79(16):10108-25.

27.

Interaction of singlet molecular oxygen with melatonin and related indoles.

Matuszak Z, Bilska MA, Reszka KJ, Chignell CF, Bilski P.

Photochem Photobiol. 2003 Nov;78(5):449-55.

PMID:
14653575
28.

Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.

Montefiori DC, Altfeld M, Lee PK, Bilska M, Zhou J, Johnston MN, Gao F, Walker BD, Rosenberg ES.

J Immunol. 2003 Apr 1;170(7):3906-14.

29.

Interaction of singlet molecular oxygen with double fluorescent and spin sensors.

Bilski P, Hideg K, Kálai T, Bilska MA, Chignell CF.

Free Radic Biol Med. 2003 Feb 15;34(4):489-95.

PMID:
12566074
31.

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.

Earl PL, Wyatt LS, Montefiori DC, Bilska M, Woodward R, Markham PD, Malley JD, Vogel TU, Allen TM, Watkins DI, Miller N, Moss B.

Virology. 2002 Mar 15;294(2):270-81.

32.

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques.

Montefiori DC, Safrit JT, Lydy SL, Barry AP, Bilska M, Vo HT, Klein M, Tartaglia J, Robinson HL, Rovinski B.

J Virol. 2001 Jul;75(13):5879-90.

33.

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.

Letvin NL, Robinson S, Rohne D, Axthelm MK, Fanton JW, Bilska M, Palker TJ, Liao HX, Haynes BF, Montefiori DC.

J Virol. 2001 May;75(9):4165-75.

34.

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG, Emini EA, Shiver JW, Letvin NL.

Science. 2000 Oct 20;290(5491):486-92.

36.

Characterization of primary isolate-like variants of simian-human immunodeficiency virus.

Crawford JM, Earl PL, Moss B, Reimann KA, Wyand MS, Manson KH, Bilska M, Zhou JT, Pauza CD, Parren PW, Burton DR, Sodroski JG, Letvin NL, Montefiori DC.

J Virol. 1999 Dec;73(12):10199-207.

37.

Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.

Montefiori DC, Collman RG, Fouts TR, Zhou JY, Bilska M, Hoxie JA, Moore JP, Bolognesi DP.

J Virol. 1998 Mar;72(3):1886-93.

38.

Vaccine evaluation studies of replication-defective SIVsmB7.

Kraiselburd EN, Salaman A, Beltrán M, Rivera M, Oliver J, Kessler M, Knezevich M, Rodriguez A, Bilska M, Montefiori D, Torres-Bauza LJ, Martinez I.

Cell Mol Biol (Noisy-le-grand). 1997 Nov;43(7):915-24.

PMID:
9449524
39.
40.

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS.

J Infect Dis. 1996 Jan;173(1):60-7.

PMID:
8537683
41.

The photooxidation of diethylhydroxylamine by rose bengal in micellar and nonmicellar aqueous solutions.

Bilski P, Motten AG, Bilska M, Chignell CF.

Photochem Photobiol. 1993 Jul;58(1):11-8.

PMID:
8378429
42.

[Prevalence of caries in permanent teeth in school children in Poland].

Potoczek S, Kaczmarek U, Bilska M, Gogol J, Granek B, Maczka M, Nowak-Malinowska H, Pastuszewska A, Szczepankiewicz W.

Czas Stomatol. 1980 Mar;33(3):185-9. Polish. No abstract available.

PMID:
6931671

Supplemental Content

Loading ...
Support Center